ICAM1 and neoplasm: However, combination with RT, although in vivo ICAM-1 blocking in distant tumors had limited effects on primary tumor growth, significantly diminished the RT-induced systemic antitumor effect in distant tumors compared with that in the RT plus isotype-matched IgG group (P <0.05; Figure 1E, F and Figure S4A, B).